News | 25.04.2024
First Patient in Zugspitze TRIAL
![Image ohne Titel](https://cdn.lmu-klinikum.de/e55f6996d45dd905/e369fbca946b/v/d1e8d9f2f212/Bildschirmfoto-2024-06-17-um-15.32.57.png)
First patient in! Zugspitze is an interdisciplinary, multicenter, prospective, randomized, phase II trial investigating the combination of SIRT and Immunotherapy in HCC.
First patient in! Zugspitze is an interdisciplinary, multicenter, prospective, randomized, phase II trial investigating the combination of SIRT and Immunotherapy in HCC.